Fresenius Kabi recalls 5% Dextrose Injection (50 mL) due to lack of sterility assurance. This could cause infections if used improperly. Contact the company for details.
Lack of Assurance of Sterility
Fresenius Kabi is recalling 50 mL vials of 5% Dextrose Injection because they may not be sterile. Using these could lead to infections, especially in medical settings.
The product may not be sterile, which can lead to infections if used in medical procedures. This is a serious risk for patients undergoing treatments that require sterile injections.
Healthcare professionals and patients using this injection for medical treatments. Those with compromised immune systems are at higher risk.
Check for the NDC number 65219-456-05 on the vial. The product was manufactured in batch 6402296 and expires July 31, 2026.
Look for the NDC number 65219-456-05 on the vial label.
The product may not be sterile, which could lead to infections if used in medical procedures.
The recall record does not specify a remedy, so contact Fresenius Kabi directly for guidance.
The recall states a lack of sterility assurance, which could cause infections, but the record does not specify serious injury risks.
We’ve drafted a message you can send Fresenius Kabi to request your refund or repair — edit it as you like.
Subject: Recall D-0435-2026 — Fresenius Kabi Fresenius Kabi Hello, I own a Fresenius Kabi that is covered by recall D-0435-2026 from Fresenius Kabi. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
